Company intelligence / Profile preview

Aquatic Life Sciences

Ferndale, WA, USA

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Syndel is a specialized pharmaceutical company focused on the aquaculture and fish health sectors. The company provides a comprehensive suite of products including anesthetics, spawning agents, disinfectants, and vaccines designed for use in fish hatcheries and aquaculture facilities. Syndel is well-known for its FDA-approved products such as Tricaine-S (MS-222) and Parasite-S (formalin). The company serves a global market, supporting fish conservation, research, and commercial fish farming operations.

Therapeutic areas: DermatologyOtherInfectious Diseases
Modalities: Small moleculePeptides
Industry: Veterinary

Partnerships

US Fish and Wildlife Service

Beyond the preview

Go deeper on Aquatic Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquatic Life Sciences.

Explore the full profile